SEC Tracker
Get the app

Design Therapeutics DSGN

Up to $300,000,000 of securities

Securities offering

Form
S-3
Filed
Importance
Routine
  1. Up to $300,000,000 of securities
  2. Common stock, preferred stock, debt, warrants
  3. May offer securities in one or more offerings

Written from the S-3 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Design Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Alector ALEC public float $115M, Jun 30, 2025
  2. Protalix BioTherapeutics PLX public float $113M, Jun 30, 2025
  3. Fate Therapeutics FATE public float $113M, Jun 30, 2025
  4. Caribou Biosciences CRBU public float $113M, Jun 30, 2025
  5. Protara Therapeutics PRTO public float $112M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.